Singapore markets closed

MDxHealth SA (0O8G.L)

LSE - LSE Delayed Price. Currency in EUR
Add to watchlist
2.8213-0.0187 (-0.66%)
At close: 05:13PM GMT
Full screen
Previous close2.8400
Open2.8005
Bid0.0000 x 0
Ask0.0000 x 0
Day's range2.8005 - 2.8213
52-week range1.9750 - 6.8000
Volume134
Avg. volume1,690
Market cap1.56M
Beta (5Y monthly)0.73
PE ratio (TTM)N/A
EPS (TTM)-0.2150
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq

    NEWS RELEASE – REGULATED INFORMATIONNOVEMBER 27, 2023, 1:00 am ET / 7:00 am CET MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq IRVINE, CA, and HERSTAL, BELGIUM – November 27, 2023 – MDxHealth SA (NASDAQ/Euronext Brussels: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, today announces the completion of the mandatory exchange under the Company's American Depositary Shares ("ADSs") f

  • GlobeNewswire

    MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference

    NEWS RELEASENovember 14, 2023, 4PM ET/ 22:00 CET MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference IRVINE, CA, and HERSTAL, BELGIUM – November 14, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH), a commercial-stage precision diagnostics company, today announced that Michael K. McGarrity, Chief Executive Officer, will participate in a fireside chat at the 35th Piper Sandler Healthcare Conference on Wednesday, November 29, 2023, at 9:00am ET. A live webcast o

  • GlobeNewswire

    MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights

    NEWS RELEASE - REGULATED INFORMATIONINSIDE INFORMATIONNOVEMBER 13, 2023, 4:00 PM ET / 22:00 CET MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights IRVINE, CA, and HERSTAL, BELGIUM – November 13, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH) ("mdxhealth" or the "Company"), a commercial-stage precision diagnostics company, today announces that it completed the share consolidation with respect to all its outstanding shares by means of a 1-for-10